Skip to content

The Families Addressing Cancer Together Intervention for Parents With Cancer

Families Addressing Cancer Together (FACT): A Pilot Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05377749
Acronym
FACT
Enrollment
47
Registered
2022-05-17
Start date
2022-07-05
Completion date
2023-02-22
Last updated
2024-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Communication, Neoplasms, Parent-Child Relations, Parenting, Parents

Brief summary

The proposed pilot randomized controlled trial will test the FACT (Families Addressing Cancer Together) intervention designed to improve parents' confidence and ability to talk about their cancer with their minor children. We will enroll 40 patients with cancer who have a minor child to participate in this single site, 6-week study. The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible and acceptable when compared with a wait-list control condition.

Detailed description

Parents with cancer are encouraged to be honest and open with their minor children about their illness. However, many lack access to professional support for their communication needs. Without this support, parents with cancer and their children experience avoidable psychosocial distress. In order to better support parental communication needs in cancer, psychosocial interventions that can be implemented across clinical practice settings are needed. To address this gap, we developed and pilot-tested FACT (Families Addressing Cancer Together) - a theory-guided, web-based psycho-educational intervention to help parents with cancer talk about their illness with their children in a developmentally appropriate way. The proposed pilot randomized controlled trial will test the feasibility and acceptability of the FACT intervention. We will enroll 40 patients with cancer who have a minor child to participate in this single site, 6-week study. The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible and acceptable when compared with a wait-list control condition. We will also explore preliminary effects of the intervention on parental communication and psychological outcomes.

Interventions

BEHAVIORALFACT

Families Addressing Cancer Together (FACT) is a web-based intervention that provides tailored communication support for parents with cancer.

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
National Cancer Institute (NCI)
CollaboratorNIH
UNC Lineberger Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Masking description

Biostatistician

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Informed consent reviewed and signed; * Age equal to or above 18 years; * Ability to understand and comply with study procedures; * Able to complete all study measures and visits in English; * Be a parent (defined as biological, adoptive, foster, or step-parent), kin caregiver (defined as a relative or someone with a significant emotional relationship who provides full-time care and nurturing of a child), or legal guardian of a child age 3 to 17 years of age who can speak and understand English; * Have a diagnosis of Stage II-IV (or equivalent) invasive solid tumor not in surveillance or survivorship

Exclusion criteria

* Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes; * Prior participation in the pilot trial or development and user testing protocol preliminary to this study; * No current or expected contact with their child; or * Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol.

Design outcomes

Primary

MeasureTime frameDescription
Families Addressing Cancer Together (FACT) Satisfaction Scale3 weeksAcceptability was measured by the FACT satisfaction scale in the intervention group using the study-specific, 6-item FACT satisfaction scale. The total score range is 0-18 with higher scores indicating more satisfaction.
Acceptability as Measured by FACT Satisfaction Scale6 weeksSatisfaction with FACT will be measured in the intervention group using the study-specific, 6-item FACT satisfaction scale. Total score range is 0-18 with higher scores indicating more satisfaction.
Acceptability as Assessed by a Semi-structured, Post-intervention Interview6 weeksSatisfaction with FACT will be assessed via semi-structured, post-intervention interviews. Regarding n's, these interviews were offered as an optional part of participation among those randomized to the intervention (FACT). 12 participants agreed to participate in the interviews.

Secondary

MeasureTime frameDescription
Recruitment Feasibility as Measured by Rate of Eligible Patients Who Consent to Study Participation6 weeksPercentage of approached patients who meet study eligibility criteria who enroll (provide informed consent) in the study.
Change From Baseline Communication Self-efficacy Using the CSESBaseline, 3 weeksChange in parental communication self-efficacy will be measured using an adapted version of the Communication Self-Efficacy Scale (CSES). The 9-item CSES measures parental communication self-efficacy on a visual analogue scale, with a total score range of 0 to 100, with higher scores meaning more self-efficacy.
Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey3 weeksFeasibility of participant retention as measured by the percentage of participants who complete at least one study survey, at the 3-week time point.
Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey Assessments at 6 Weeks.6 weeksPercentage of enrolled participants who complete at least one study survey (any) at the 6-week time point.The number of participants who completed the assessment,

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 07/05/2022 through 02/22/2023 at one cancer center in North Carolina.

Pre-assignment details

During this period, there have been 93 potential subjects who could be approached for screening. In total 47 subjects were found eligible for the study and started.

Participants by arm

ArmCount
FACT Intervention
Families Addressing Cancer Together (FACT) intervention plus questionnaires FACT: Families Addressing Cancer Together (FACT) is a web-based intervention that provides tailored communication support for parents with cancer.
24
Wait-list Control Condition
Participants assigned to the waitlist control condition only complete questionnaires during the study period. After they have completed their 6-week study activities, they will receive access to the FACT intervention.
23
Total47

Withdrawals & dropouts

PeriodReasonFG000FG001
3 WeeksLost to Follow-up24
3 WeeksWithdrawal by Subject11

Baseline characteristics

CharacteristicFACT InterventionWait-list Control ConditionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
24 Participants23 Participants47 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants2 Participants2 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
24 Participants21 Participants45 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants1 Participants2 Participants
Race (NIH/OMB)
Black or African American
7 Participants4 Participants11 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants1 Participants1 Participants
Race (NIH/OMB)
White
15 Participants15 Participants30 Participants
Region of Enrollment
United States
24 participants23 participants47 participants
Sex: Female, Male
Female
18 Participants20 Participants38 Participants
Sex: Female, Male
Male
6 Participants3 Participants9 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Acceptability as Assessed by a Semi-structured, Post-intervention Interview

Satisfaction with FACT will be assessed via semi-structured, post-intervention interviews. Regarding n's, these interviews were offered as an optional part of participation among those randomized to the intervention (FACT). 12 participants agreed to participate in the interviews.

Time frame: 6 weeks

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Families Addressing Cancer Together (FACT) InterventionAcceptability as Assessed by a Semi-structured, Post-intervention InterviewYes11 Participants
Families Addressing Cancer Together (FACT) InterventionAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNot reported1 Participants
Families Addressing Cancer Together (FACT) InterventionAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNo0 Participants
BeneficialAcceptability as Assessed by a Semi-structured, Post-intervention InterviewYes11 Participants
BeneficialAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNot reported1 Participants
BeneficialAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNo0 Participants
RecommendedAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNo5 Participants
RecommendedAcceptability as Assessed by a Semi-structured, Post-intervention InterviewYes7 Participants
RecommendedAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNot reported0 Participants
ShortcomingsAcceptability as Assessed by a Semi-structured, Post-intervention InterviewYes4 Participants
ShortcomingsAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNot reported0 Participants
ShortcomingsAcceptability as Assessed by a Semi-structured, Post-intervention InterviewNo8 Participants
Primary

Acceptability as Measured by FACT Satisfaction Scale

Satisfaction with FACT will be measured in the intervention group using the study-specific, 6-item FACT satisfaction scale. Total score range is 0-18 with higher scores indicating more satisfaction.

Time frame: 6 weeks

Population: Subjects joined to the study and completed satisfaction survey.

ArmMeasureValue (MEAN)Dispersion
Families Addressing Cancer Together (FACT) InterventionAcceptability as Measured by FACT Satisfaction Scale13.15 score on a scaleStandard Deviation 1.83
Primary

Families Addressing Cancer Together (FACT) Satisfaction Scale

Acceptability was measured by the FACT satisfaction scale in the intervention group using the study-specific, 6-item FACT satisfaction scale. The total score range is 0-18 with higher scores indicating more satisfaction.

Time frame: 3 weeks

Population: Participants who started the intervention and completed the post-intervention survey.

ArmMeasureValue (MEAN)Dispersion
Families Addressing Cancer Together (FACT) InterventionFamilies Addressing Cancer Together (FACT) Satisfaction Scale16.24 score on a scaleStandard Deviation 2.48
Secondary

Change From Baseline Communication Self-efficacy Using the CSES

Change in parental communication self-efficacy will be measured using an adapted version of the Communication Self-Efficacy Scale (CSES). The 9-item CSES measures parental communication self-efficacy on a visual analogue scale, with a total score range of 0 to 100, with higher scores meaning more self-efficacy.

Time frame: Baseline, 6 weeks

Population: Subjects who joined to the study and completed the assessment.

ArmMeasureValue (MEAN)Dispersion
Families Addressing Cancer Together (FACT) InterventionChange From Baseline Communication Self-efficacy Using the CSES9.47 score on a scaleStandard Deviation 16.08
BeneficialChange From Baseline Communication Self-efficacy Using the CSES0.96 score on a scaleStandard Deviation 14.1
Secondary

Change From Baseline Communication Self-efficacy Using the CSES

Change in parental communication self-efficacy will be measured using an adapted version of the Communication Self-Efficacy Scale (CSES). The 9-item CSES measures parental communication self-efficacy on a visual analogue scale, with a total score range of 0 to 100, with higher scores meaning more self-efficacy.

Time frame: Baseline, 3 weeks

Population: Participants who started the study and completed the post-intervention survey.

ArmMeasureValue (MEAN)Dispersion
Families Addressing Cancer Together (FACT) InterventionChange From Baseline Communication Self-efficacy Using the CSES6.46 score on a scaleStandard Deviation 14.4
BeneficialChange From Baseline Communication Self-efficacy Using the CSES2.85 score on a scaleStandard Deviation 9.28
Secondary

Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey

Feasibility of participant retention as measured by the percentage of participants who complete at least one study survey, at the 3-week time point.

Time frame: 3 weeks

Population: Participants who started the study and completed the post-intervention survey.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Families Addressing Cancer Together (FACT) InterventionFeasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey21 Participants
BeneficialFeasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey18 Participants
Secondary

Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey Assessments at 6 Weeks.

Percentage of enrolled participants who complete at least one study survey (any) at the 6-week time point.The number of participants who completed the assessment,

Time frame: 6 weeks

Population: Subjects joined to the study and completed the assessment.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Families Addressing Cancer Together (FACT) InterventionFeasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey Assessments at 6 Weeks.23 Participants
BeneficialFeasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey Assessments at 6 Weeks.17 Participants
Secondary

Recruitment Feasibility as Measured by Rate of Eligible Patients Who Consent to Study Participation

Percentage of approached patients who meet study eligibility criteria who enroll (provide informed consent) in the study.

Time frame: 6 weeks

Population: All participants were invited to the study including both arms.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Families Addressing Cancer Together (FACT) InterventionRecruitment Feasibility as Measured by Rate of Eligible Patients Who Consent to Study ParticipationNumber of Eligible Participants for Screening93 Participants
Families Addressing Cancer Together (FACT) InterventionRecruitment Feasibility as Measured by Rate of Eligible Patients Who Consent to Study ParticipationNumber of Participants Consented and Started47 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026